Table 1 KEGG analysis results
From: TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas
hsa05200: Pathways in cancer (42) | AKT3, APC, APPL1, BIRC2, BIRC7, BMP2, CDC42, CDK6, CEBPA, CHUK, CUL2, DAPK1, DCC, E2F3, FAS, FGF17, FGF22, FGF6, FGF9, FLT3, FZD10, FZD3, GLI1, HGF, KITLG, KRAS, MAPK8, MECOM, PDGFRB, PIAS2, PIK3CB, PIK3CG, PLD1, PTGS2, RAF1, RXRG, SHH, SMAD4, SOS1, SPI1, WNT1, WNT5B |
hsa04115: p53 signaling pathway (18) | ATM, ATR, BBC3, CCNB1, CCNB2, CCND2, CDK1, CDK6, FAS, GADD45A, GADD45B, IGFBP3, MDM4, SERPINE1, SESN1, SESN3, TP53AIP1, ZMAT3 |
hsa04110: Cell cycle (20) | ANAPC4, ATM, ATR, CCNB1, CCNB2, CCND2, CDC23, CDK1, CDK6, CDKN2D, E2F3, E2F5, GADD45A, GADD45B, ORC2, ORC4, ORC5, SMAD4, STAG1, TTK |
hsa04210: Apoptosis (15) | AIFM1, AKT3, ATM, BIRC2, BIRC7, CASP6, CHUK, FAS, IRAK3, IRAK4, NGF, PIK3CB, PIK3CG, PPP3CB, PRKACG |
hsa04151: PI3K-Akt signaling pathway (40) | AKT3, CCND2, CDK6, CHUK, COL11A1, COL11A2, COL3A1, COL5A3, CREB3L1, CSF3, FGF17, FGF22, FGF6, FGF9, FOXO3, GNGT1, HGF, IFNA13, IFNAR1, ITGB7, JAK2, JAK3, KITLG, KRAS, NGF, NOS3, NR4A1, PCK1,PDGFRB, PIK3CB, PIK3CG, PKN2, PPP2R2A, PPP2R3A, PPP2R3C, PPP2R5A, RAF1, SOS1, TCL1B, THBS4 |
hsa04630: Jak-STAT signaling pathway (29) | AKT3, CCND2, CISH, CRLF2, CSF3, IFNA13, IFNAR1, IFNW1, IL10RB, IL11RA, IL12B, IL12RB1, IL13RA1, IL20, IL6ST, JAK2, JAK3, LIF, LIFR, PIAS2, PIK3CB, PIK3CG, PIM1, SOCS1, SOCS4, SOS1, SPRED1, SPRED3, STAM2 |